Clinical Trial Update: Psilocybin Microdosing With Psychotherapy for Treatment-Resistant Depression [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating psilocybin microdosing with psychotherapy for treatment-resistant depression; recruitment is ongoing at Beersheva Mental Health Center.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Treatment-resistant Depression

Drugs mentioned

• Psilocybin (psilocybin)

Snippet

Sponsor: Beersheva Mental Health Center | Conditions: Treatment Resistant Depression | Phase 2 | Status: RECRUITING